Ebdrup, Bjørn H.
University of Copenhagen
11 papers on CoChatORCID 0000-0002-2590-5055
Most cited papers
- Verified
Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis
Siskind, D., Hahn, M., Correll, C. U., Fink‐Jensen, A., Russell, A. W., Bak, N., Broberg, B. V., Larsen, J., Ishøy, P. L., Vilsbøll, T., et al. (2019) · Diabetes, Obesity and Metabolism
Schizophrenia research and treatmentPharmacology and Obesity Treatment
Cited by 144
- Verified
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis
ENIGMA Clinical High Risk for Psychosis Working Group, Jalbrzikowski, M., Hayes, R. A., Wood, S. J., Nordholm, D., Zhou, J. H., Fusar-Poli, P., Uhlhaas, P. J., Takahashi, T., Sugranyes, G., et al. (2021) · JAMA Psychiatry
Schizophrenia research and treatmentPsychopathy, Forensic Psychiatry, Sexual Offending
Cited by 137
- Verified
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
Baandrup, L., Ebdrup, B. H., Rasmussen, J. Ø., Lindschou, J., Gluud, C., & Glenthøj, B. Y. (2018) · Cochrane Database of Systematic Reviews
Pharmaceutical Practices and Patient OutcomesSubstance Abuse Treatment and Outcomes
Cited by 128
- Verified
Effect of GLP ‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: a randomized, placebo‐controlled trial
Ishøy, P. L., Knop, F. K., Broberg, B. V., Bak, N., Andersen, U. B., Jørgensen, N. R., Holst, J. J., Glenthøj, B. Y., & Ebdrup, B. H. (2017) · Diabetes, Obesity and Metabolism
Schizophrenia research and treatmentPharmacology and Obesity Treatment
Cited by 102
- Verified
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series
Prasad, F., De, R., Korann, V., Chintoh, A. F., Remington, G., Ebdrup, B. H., Siskind, D., Knop, F. K., Vilsbøll, T., Fink-Jensen, A., et al. (2023) · Therapeutic Advances in Psychopharmacology
Pharmacology and Obesity TreatmentSchizophrenia research and treatment
Cited by 88
- Verified
Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study
Rohde, C., Polcwiartek, C., Kragholm, K., Ebdrup, B. H., Siskind, D., & Nielsen, J. (2018) · Acta Psychiatrica Scandinavica
Schizophrenia research and treatmentCardiac Health and Mental Health
Cited by 71
- Verified
The impact of weight gain on antipsychotic nonadherence or discontinuation: a systematic review and meta-analysis
De, R., Smith, E. C. C., Navagnanavel, J., Au, E., Maksyutynska, K., Papoulias, M., Singh, R., Panganiban, K. J., Humber, B., Mohr, G. H., et al. (2025) · Acta Psychiatrica Scandinavica
Schizophrenia research and treatmentMedication Adherence and Compliance
Cited by 39
- Verified
Erratum: Effect of GLP ‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: A randomized, placebo‐controlled trial
Ebdrup, B. H., Broberg, B. V., Ishøy, P. L., Bak, N., Andersen, U. B., Jørgensen, N. R., Holst, J. J., Knop, F. K., & Glenthøj, B. Y. (2018) · Diabetes, Obesity and Metabolism
Pharmacology and Obesity TreatmentSchizophrenia research and treatment
Cited by 35
- Verified
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
Ebdrup, B. H., Knop, F. K., Ishøy, P. L., Rostrup, E., Fagerlund, B., Lublin, H., & Glenthøj, B. (2012) · BMC Medicine
Schizophrenia research and treatmentPharmacology and Obesity Treatment
Cited by 34
- Verified
Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density
Eriksson, R., Broberg, B. V., Ishøy, P. L., Bak, N., Andersen, U. B., Jørgensen, N. R., Knop, F. K., & Ebdrup, B. H. (2019) · Frontiers in Psychiatry
Bone health and osteoporosis researchSchizophrenia research and treatment
Cited by 26
- Verified
Postprandial prolactin suppression appears absent in antipsychotic-treated male patients
Coello, K., Broberg, B. V., Bak, N., Madsen, A., Mortensen, H. B., Søgaard, B., Szecsi, P. B., Knop, F. K., Lublin, H., & Ebdrup, B. H. (2015) · Psychoneuroendocrinology
Schizophrenia research and treatmentGrowth Hormone and Insulin-like Growth Factors
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free